- Home
- ISRG vs TMO Comparison
ISRG vs TMO Comparison
Compare ISRG & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- TMO
- Stock Information
- Founded
- ISRG 1995
- TMO 1956
- Country
- ISRG United States
- TMO United States
- Employees
- ISRG N/A
- TMO N/A
- Industry
- ISRG Medical/Dental Instruments
- TMO Industrial Machinery/Components
- Sector
- ISRG Health Care
- TMO Industrials
- Exchange
- ISRG Nasdaq
- TMO Nasdaq
- Market Cap
- ISRG 182.1B
- TMO 203.5B
- IPO Year
- ISRG 2000
- TMO N/A
- Fundamental
- Price
- ISRG $536.51
- TMO $403.04
- Analyst Decision
- ISRG Strong Buy
- TMO Buy
- Analyst Count
- ISRG 18
- TMO 19
- Target Price
- ISRG $590.59
- TMO $603.84
- AVG Volume (30 Days)
- ISRG 1.8M
- TMO 2.8M
- Earning Date
- ISRG 04-22-2025
- TMO 04-23-2025
- Dividend Yield
- ISRG N/A
- TMO 0.43%
- EPS Growth
- ISRG 23.31
- TMO 9.37
- EPS
- ISRG 6.83
- TMO 17.06
- Revenue
- ISRG $8,714,900,000.00
- TMO $42,898,000,000.00
- Revenue This Year
- ISRG $17.66
- TMO $3.25
- Revenue Next Year
- ISRG $15.45
- TMO $6.54
- P/E Ratio
- ISRG $78.55
- TMO $23.63
- Revenue Growth
- ISRG 19.08
- TMO 0.95
- 52 Week Low
- ISRG $379.67
- TMO $402.81
- 52 Week High
- ISRG $616.00
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- ISRG 61.97
- TMO 31.86
- Support Level
- ISRG $522.95
- TMO $415.38
- Resistance Level
- ISRG $546.56
- TMO $415.75
- Average True Range (ATR)
- ISRG 13.68
- TMO 12.87
- MACD
- ISRG 4.72
- TMO 0.81
- Stochastic Oscillator
- ISRG 87.72
- TMO 2.16
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).